Header Logo

Connection

JASON HOU to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications JASON HOU has written about Diabetes Mellitus, Type 2.
JASON HOU
Connection Strength
0.374
Diabetes Mellitus, Type 2
  1. Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613-627. Curr Med Res Opin. 2022 12; 38(12):2241-2242.
    View in: PubMed
    Score: 0.374
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.